Regeneron Pharmaceuticals (REGN)
Operating Cash Flow Growth
-6.34%
TTM · Period ending:
REGN Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-6.34%period ending
Latest reported-6.34%period ending
REGN TTM Cash from Operations YoY % (-116.52% → -6.34%)
Year-over-year change
High-resolution chart · PNG
REGN operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -24.7771% | |
| 10.3106% | |
| -102.2464% | |
| 35.3208% | |
| -41.3425% | |
| -52.6875% | |
| -35.2941% | |
| -1,792.8571% | |
| -100% | |
| -108.6957% | |
| -67.2131% | |
| 84.9462% | |
| 50% | |
| 57.9268% | |
| 69.9507% | |
| 48.6188% | |
| 34.8214% | |
| 13.2275% | |
| -11.5385% | |
| 42.9022% | |
| 14.8289% | |
| -4.4199% | |
| 11.2195% | |
| -75.1381% | |
| -44.5055% | |
| 43.0818% | |
| 31.8937% | |
| 33.2103% | |
| 26.9076% | |
| -49.2958% | |
| -75% | |
| -115.0794% | |
| -116.5217% |